OpGen Inc (OPGN)
0.498
+0.02
(+3.32%)
USD |
NASDAQ |
May 07, 16:00
0.498
0.00 (0.00%)
After-Hours: 20:00
OpGen Research and Development Expense (Quarterly): 1.202M for Sept. 30, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 1.202M |
| June 30, 2023 | 1.389M |
| March 31, 2023 | 1.813M |
| December 31, 2022 | 1.552M |
| September 30, 2022 | 2.031M |
| June 30, 2022 | 2.274M |
| March 31, 2022 | 2.316M |
| December 31, 2021 | 2.855M |
| September 30, 2021 | 2.382M |
| June 30, 2021 | 2.860M |
| March 31, 2021 | 2.814M |
| December 31, 2020 | 3.335M |
| September 30, 2020 | 2.434M |
| June 30, 2020 | 2.979M |
| March 31, 2020 | 1.218M |
| December 31, 2019 | 1.052M |
| September 30, 2019 | 1.139M |
| June 30, 2019 | 1.154M |
| March 31, 2019 | 1.776M |
| December 31, 2018 | 1.856M |
| Date | Value |
|---|---|
| September 30, 2018 | 1.286M |
| June 30, 2018 | 1.304M |
| March 31, 2018 | 1.230M |
| December 31, 2017 | 1.485M |
| September 30, 2017 | 1.513M |
| June 30, 2017 | 1.762M |
| March 31, 2017 | 2.122M |
| December 31, 2016 | 2.334M |
| September 30, 2016 | 2.179M |
| June 30, 2016 | 2.334M |
| March 31, 2016 | 1.953M |
| December 31, 2015 | 2.106M |
| September 30, 2015 | 1.789M |
| June 30, 2015 | 0.9997M |
| March 31, 2015 | 1.109M |
| December 31, 2014 | 1.293M |
| September 30, 2014 | 1.030M |
| June 30, 2014 | 1.247M |
| March 31, 2014 | 0.9528M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
1.052M
Minimum
Dec 2019
3.335M
Maximum
Dec 2020
2.044M
Average
2.152M
Median
Research and Development Expense (Quarterly) Benchmarks
| Ainos Inc | 2.237M |
| Zomedica Corp | 3.099M |
| LENSAR Inc | 1.463M |
| Eargo Inc (DELISTED) | 4.742M |
| Intelligent Bio Solutions Inc | 0.3485M |